Most Internet-tomography problems such as shared congestion detection depend on network measurements. Usually, such measurements are carried out in multiple locations inside the network and relied on local clocks. These clocks usually skewed with time making these measurements unsynchronized and thereby degrading the performance of most techniques. Recently, shared congestion detection has become an important issue in many computer networked applications such as multimedia streaming and
peer-to-peer file sharing. One of the most powerful techniques that employed in literature is based on Discrete Wavelet Transform (DWT) with cross-correlation operation to determine the state of the congestion. Wavelet transform is used as a de-noising tool to reduce the effects of both clock skew and queuing delay fluctuations on the decision of congestion type. Since, classical Discrete Wavelet Transform (DWT) is not shift-invariant transform which is a very useful property particularly in signal de-noising problems. Therefore, another transform called Stationary Wavelet Transform (SWT) that possesses shiftinvariant property is suggested and used instead of DWT. The modified technique exhibits a better performance in terms of the time required to correctly detect the state of congestion especially with the existence of clock skew problem. The suggested technique is tested using simulations under different
environments.
Shared Congestion Detection: A Comparative Study
shared congestion
clock skew
shift invariant
cross correlation
soft-threshold operation.
Publication Date
Fri Aug 01 2025
Journal Name
Microbial Pathogenesis
Antibacterial and therapeutic effects of vancomycin-resistant Staphylococcus aureus bacteriocin (VRSAcin) in the treatment of VRSA skin infection in mice
Vancomycin Staphylococcus aureus (VRSA) is a strain of S. aureus that is considered the main cause of bacterial
skin and soft tissue infections. It has acquired resistance to vancomycin and represents a therapeutic challenge.
The current study aimed to compare the possible therapeutic effects of VRSA bacteriocin (VRSAcin) on the
treatment of skin infection in mice with those of an antibiotic (linezolid). The results showed that of the fifty
swabs obtained from human skin wounds. One isolate was selected for VRSAcin extraction depending on its
antibiotic resistance using an antibiotic susceptibility test.An agar well diffusion test was used to determine
bacteriocin’s antibacterial activity
as well as its a minimum inhibitory concentration
minimum bactericidal
concentration
and antibiofilm efficiency against gram-positive and gram-negative bacteria that were resistant to
many medicines. The freshly developed antibacterial substance VRSAcin shows promise. Bacteriocin from VRSA
was extracted and studied the optimal conditions for the Production following Purification of bacteriocin by
ammonium sulfate precipitation followed by cation-exchange chromatography. The molecular weight of
bacteriocin about (29 kDa) were determined by Sodium Dodecyl Sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). The typical conditions for the production of VRSAcin include a pH of 7 and a temperature of 37 ◦C
for 48 h. In mice
VRSA-contaminated wounds revealed severe tissue distraction and inflammation that extended
to the hypodermis
while VRSA-treated skin showed mild changes and localized lesions to the epidermis and
upper dermis. The skin of linezolid ointment-treated mice showed moderate to severe changes. In conclusion
VRSA strain infections in human burned skin were more common than expected. In vivo studies in mice indicated
that wounded skin infected with VRSA can be treated with VRSAcin as an antibacterial agent that promotes
healing processes with obvious superiority to linezolid ointment. As a result
the VRSA develops bacteriocins that
are appropriate for regulating AMR
Gram-positive and Gram-negative bacteria
and may be useful in wound
dressings.
(5)
(4)
